Effects of Galcanezumab on Acute Medication Use and Health Care Resource Utilization in Treatment-Resistant Migraine: Results from Randomized, Double Blind, Placebo-Controlled Clinical Trial, Conquer. Headache Med 2020, 11 (Supplement), 27. https://doi.org/10.48208/HeadacheMed.2020.Supplement.27.